Progress in clinical research on the integration of Chinese and Western medicines for treating primary liver cancer

Progress in clinical research on the integration of Chinese and Western medicines for treating primary liver cancer

Primary liver cancer (PLC) is one of the most common malignant tumors in China. PLC is characterized by insidious onset, rapid progress, poor quality of life, and short survival time. Notably, current treatment strategies remain unsatisfactory. Traditional Chinese medicines (TCM) have been used to t...

Full description

Bibliographic Details
Main Authors: Kaiqi Liu, Hongliang Li, Jufeng Duan, Xiaojing Chen, Xiongjie Yu, Xianhe Wang, Ming Liu, Bei Li, Minglun Li, Yibin Feng, Xiaojun Cai, Xuanbin Wang
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Journal of Traditional Chinese Medical Sciences
Subjects:
Traditional Chinese medicines
Primary liver cancer
Integrative medicine
Clinical research
Online Access:http://www.sciencedirect.com/science/article/pii/S2095754821000442

Internet

http://www.sciencedirect.com/science/article/pii/S2095754821000442

Similar Items